MNDL BIO LTD

MNDL Bio is specializing in gene expression optimization through its cloud-based platform. The focus lies in transforming trial and-error processes in bio-manufacturing into a data-driven design, significantly reducing R&D timelines and cutting cost.

MNDL is a developer of a computational platform, designed to optimize the gene expression process. The company's platform utilizes AI to analyze and optimize the production of recombinant proteins, enabling researchers to significantly accelerate development timelines and reduce costs.

Foodtech & agtech, pharmaceuticals, biofuels and energy, biomaterials, biotechnology firms.

Steve Grun - CEO & Co-Founder